Product pipeline

science-innovation

Product pipeline

Through our pipeline, we are researching life-changing medicines that make birth, life and living possible.

Reproductive Medicine & Maternal Health

Project / Indication Phase II Phase III Filed
FE 202767
Lactation (merotocin)
FE 999051
Endometriosis (quinagolide)
Menopur® Pen (China)
Infertility (gonadotrophin)
Menopur® Pen (US)
Infertility (gonadotrophin)
Menopur® Pen (Japan)
Infertility (gonadotrophin)
Rekovelle® (Pan-Asia, India and US)
Infertility (follitropin delta)
Lutrepulse® (US)
Infertility (gonadotropin GnRH)
Menopur® Pen (EU)
Infertility (gonadotrophin)
Rekovelle® (Japan)
Infertility (follitropin delta)

Gastroenterology

Project / Indication Phase II Phase III Filed
RBX7455 oral formulation
Recurrent clostridioides difficile infection
RBX2660 enema
Recurrent clostridioides difficile infection
Cortiment®MMX® (Japan)
Ulcerative colitis (budesonide)
Cortiment®MMX® * microscopic colitis
Ulcerative colitis (budesonide)
Pentasa® enema (China)
Ulcerative colitis (mesalazine)

Urology & Uro-oncology

Project / Indication Phase II Phase III Filed
FE 992026
Primary Nocturnal Enuresis, Diabetes Insipidus and Nocturia (desmopressin)
rAd-IFN/Syn3** (US)
High-grade non-muscle invasive bladder cancer